Aarti Drugs Schedules Board Meeting to Consider Q2FY27 Audited Results
Aarti Drugs Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Aarti Drugs Schedules Board Meeting to Consider Q2FY27 Audited Results Aarti Drugs Limited has scheduled its Board of Directors meeting for 3rd Nov'26 to consider, approve, and take on record the audited financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the company's trading window remains closed and will reopen 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Aarti Drugs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Transcript of Q2&H1 FY27 Earning Conference call 路 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations, 2015 路 06 Nov 2026
- Audio recording for conference call for Analyst and Investors 路 05 Nov 2026
- Investor Presentation for Q2 FY27 路 04 Nov 2026
- Press release on Financial results for Quarter and Half year ended September 2026 路 04 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Aarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
